Keros Therapeutics Inc (KROS)

Nov 20, 2025

Latham & Watkins Advises on Keros Therapeutics, Inc.’s US$194.4 Million Tender Offer - Legal Desire Media and Insights

Nov 20, 2025

Nov 20, 2025

Keros Therapeutics announces final results of tender offer - MarketScreener

Nov 20, 2025

Nov 20, 2025

[SC TO-I/A] Keros Therapeutics, Inc. Amended Issuer Tender Offer | KROS SEC FilingForm SC TO-I/A - Stock Titan

Nov 20, 2025

Nov 20, 2025

Keros Therapeutics (Nasdaq: KROS) completes $194M tender offer, buying 35.9% of shares - Stock Titan

Nov 20, 2025

Nov 20, 2025

Keros Therapeutics (NASDAQ:KROS) Shares Gap DownHere's Why - MarketBeat

Nov 20, 2025

Nov 20, 2025

Is Keros Therapeutics Inc. stock reversal real or fakeWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Keros Therapeutics reports oversubscribed $194.4 million tender offer By Investing.com - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Can Keros Therapeutics Inc. stock maintain operating margins2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer - MarketScreener

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics Reports Third Quarter 2025 Financial Results - Sahm

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics reports oversubscribed $194.4 million tender offer - Investing.com

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics Announces Preliminary Results of Tender Offer - MarketScreener

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics (Nasdaq: KROS) to Repurchase 10.95M Shares for $194.4M in Tender Offer - Stock Titan

Nov 19, 2025

Nov 18, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st

Nov 18, 2025

Nov 18, 2025

How to manage a losing position in Keros Therapeutics Inc.Portfolio Value Report & Free Accurate Trade Setup Notifications - newser.com

Nov 18, 2025

Nov 16, 2025

How to recover losses in Keros Therapeutics Inc. stockJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com

Nov 16, 2025

Nov 16, 2025

Los Angeles Capital Management LLC Purchases New Stake in Keros Therapeutics, Inc. $KROS - MarketBeat

Nov 16, 2025

Nov 16, 2025

Is Keros Therapeutics Inc. stock attractive for income investors2025 Buyback Activity & Reliable Entry Point Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Keros Therapeutics, Inc. $KROS - MarketBeat

Nov 16, 2025

Nov 15, 2025

Will Keros Therapeutics Inc. stock rally after Fed decisionsWeekly Profit Summary & Daily Chart Pattern Signals - newser.com

Nov 15, 2025

Nov 15, 2025

Can trapped investors hope for a rebound in Keros Therapeutics Inc.2025 Volatility Report & Safe Entry Momentum Tips - newser.com

Nov 15, 2025

Nov 15, 2025

Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why - MSN

Nov 15, 2025

Nov 15, 2025

Will Keros Therapeutics Inc. price bounce be sustainable2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com

Nov 15, 2025

Nov 14, 2025

Evaluating Keros Therapeutics Inc. with trendline analysisEntry Point & Short-Term Trading Opportunity Alerts - newser.com

Nov 14, 2025

Nov 14, 2025

Can volume confirm reversal in Keros Therapeutics Inc.July 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com

Nov 14, 2025

Nov 14, 2025

Will Keros Therapeutics Inc. stock return to pre crisis levelsJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com

Nov 14, 2025

Nov 13, 2025

Keros Therapeutics' (KROS) Outperform Rating Reiterated at Oppenheimer - MarketBeat

Nov 13, 2025

Nov 12, 2025

Oppenheimer Reiterates Keros Therapeutics (KROS) Outperform Recommendation - Nasdaq

Nov 12, 2025

Nov 12, 2025

Oppenheimer Adjusts Keros Therapeutics Price Target to $27 From $23, Maintains Outperform Rating - MarketScreener

Nov 12, 2025

Nov 12, 2025

Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00 - MarketBeat

Nov 12, 2025

Nov 11, 2025

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - MSN

Nov 11, 2025

Nov 11, 2025

Wells Fargo Maintains Keros Therapeutics (KROS) Overweight Recommendation - Nasdaq

Nov 11, 2025

Nov 11, 2025

KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig - GuruFocus

Nov 11, 2025

Nov 11, 2025

KROS vs. ARGX: Which Stock Is the Better Value Option? - MSN

Nov 11, 2025

Nov 11, 2025

Keros Therapeutics, Inc. : Wells Fargo Cuts T - 富途牛牛

Nov 11, 2025

Nov 10, 2025

How interest rate cuts could boost Keros Therapeutics Inc. stockDay Trade & AI Enhanced Execution Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Why Keros Therapeutics Inc. stock remains undervaluedJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com

Nov 10, 2025